42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1245929
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 654e1ac6-d8c2-4598-b337-549c32a9cfc5
[Document ID] => 1245929
[Document naam] => FW: AstraZeneca - AZD1222 US Phase III trial met primary efficacyendpoint in preventing COVID-19 at interim analysis
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1245929
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1245929
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
[DocumentPublicationDate] => 22 maart 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 08:10:49
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 08:10:49
)
Document: VWS-WOO-08-1245929
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210322
Geregistreerde documentnaam: FW: AstraZeneca - AZD1222 US Phase III trial met primary efficacyendpoint in preventing COVID-19 at interim analysis
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_SectionDownloadButton | 1 | 2025-09-01 16:32:58 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 16:32:58 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 16:32:58 |
| document_SectionHistory | 1 | 2025-06-22 23:45:23 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over FW: AstraZeneca - AZD1222 US Phase III trial met primary efficacyendpoint in preventing COVID-19 at interim analysis (documentnummer 1eec1b43-385d-697a-b669-bb3705657b16) | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:45:23 |
| document_SectionLinked | 1 | 2025-06-22 23:45:23 |
| document_SectionRequest | 1 | 2025-06-22 23:45:23 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 2021 | 2025-06-22 23:45:23 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo | 2025-06-22 23:45:23 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 2021 | 2025-06-22 23:45:23 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 23 november 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties & Medicatie maart 2021. | 2025-06-22 23:45:23 |
| Request_Periode | Maart 2021 | 2025-06-22 23:45:23 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:45:23 |
| Request_Datum besluit | 23 november 2023 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking | 15.961 documenten, 29.047 pagina's Inventarislijst | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_documenten | 15.961 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_paginas | 29.047 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/inventory | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:45:23 |
| document_documentName | FW: AstraZeneca - AZD1222 US Phase III trial met primary efficacyendpoint in preventing COVID-19 at interim analysis | 2025-06-22 23:45:23 |
| document_documentType | E-mailbericht | 2025-06-22 23:45:23 |
| document_documentPublicationDate | 2021-03-22 | 2025-06-22 23:45:23 |
| document_documentNumber | VWS-WOO-08-1245929 | 2025-06-22 23:45:23 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:45:23 |
| document_SectionHTMLDataDivs | 4 | 2025-06-22 23:45:23 |
| document_SectionAbout | 1 | 2025-06-22 23:45:23 |
| About_Datum document | 22 maart 2021 | 2025-06-22 23:45:23 |
| About_Type bronbestand | E-mailbericht, 3 pagina's | 2025-06-22 23:45:23 |
| About_Type bronbestand_paginas | 3 | 2025-06-22 23:45:23 |
| About_Download als | PDF (552.33 KB) | 2025-06-22 23:45:23 |
| About_Documentnummer | 1245929 | 2025-06-22 23:45:23 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:45:23 |
| History Datum_1 | 30 mei 2024 19:18 | 2025-06-21 06:28:02 |
| History Actie_3 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_4 | 30 mei 2024 18:21 | 2025-06-21 06:28:02 |
| History Actie_4 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_5 | 30 mei 2024 16:51 | 2025-06-21 06:28:02 |
| History Actie_5 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_6 | 30 mei 2024 16:37 | 2025-06-21 06:28:02 |
| History Actie_6 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_7 | 30 mei 2024 15:03 | 2025-06-21 06:28:02 |
| History Actie_7 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_8 | 30 mei 2024 14:51 | 2025-06-21 06:28:02 |
| History Actie_8 | Bronbestand toegevoegd (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_2 | 30 mei 2024 19:14 | 2025-06-21 06:28:02 |
| History Actie_1 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| History Datum_3 | 30 mei 2024 18:36 | 2025-06-21 06:28:02 |
| History Actie_2 | Bronbestand vervangen (pdf, 552.33 KB) | 2025-06-21 06:28:02 |
| DocumentDownload_linkname | Download (pdf, 552.33 KB) | 2025-04-19 21:08:29 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/document/1eec1b43-385d-697a-b669-bb3705657b16 | 2025-04-19 21:08:29 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1245929.pdf | 2025-04-19 21:08:29 |
Archiefversies (6 rijen)
Archiefrij 1 — 2025-09-07 17:26:29
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1245929.pdf
documentName: VWS-WOO-08-1245929.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 565585
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:26:29
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:26:29
lastSeen: 2025-09-07 17:26:29
text: 1245929
To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]
Cc: @minvws.nl]
From: 5.1.2e N12
Sent: Mon3/22/20218:08:43 AM
Subject: FW: AstraZeneca-AZD1222 USPhase llltrial met primary efficacyendpoint inpreventing COVID-19 atinterim analysis
Received:Mon 3/22/2021 8:08:56 AM
Beste 2e
Jullie stonden...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 66bafb3f511bddc460cb60bcfb10f0da0f7c540d2ec33c453b1220a6af7e8929
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_49245_afee8287ffb72a9527e6e58968f315cd
textDigestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1245929
Archiefrij 2 — 2025-09-04 17:12:23
fromFile: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
documentName: VWS-WOO-08-1245929.pdf
documentType: pdf
documentCompressedSize: 260167
documentSize: 565585
documentCompressRatio: 45.99962870302431
documentDateModified: 2025-05-01 20:46:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:12:23
lastSeen: 2025-09-04 17:12:23
text: 1245929 51.2e To: 5.1.2e @minvws.nl]; BE. BE IEEE | Cc: @minvws.nl] 5.1.2e From: Sent: Mon @minvws.nl] N12 3/22/2021 8:08:43 AM FW: AstraZeneca AZD1222 US Phase lll trial met primary efficacyendpoint in preventing COVID-19 at interim analysis Subject: - ...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 66bafb3f511bddc460cb60bcfb10f0da0f7c540d2ec33c453b1220a6af7e8929
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip_6320
textDigestSHA256: 86356d6f9cc28e92b63cebfdde5ffb46b95cc5108f815b63471b60e1c4d88316
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08-1245929
Archiefrij 3 — 2025-09-04 17:10:20
fromFile: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
documentName: VWS-WOO-08-1245929.pdf
documentType: pdf
documentCompressedSize: 260167
documentSize: 565585
documentCompressRatio: 45.99962870302431
documentDateModified: 2025-05-01 20:46:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:10:20
lastSeen: 2025-09-04 17:10:20
text: 1245929 51.2e To: 5.1.2e @minvws.nl]; BE. BE IEEE | Cc: @minvws.nl] 5.1.2e From: Sent: Mon @minvws.nl] N12 3/22/2021 8:08:43 AM FW: AstraZeneca AZD1222 US Phase lll trial met primary efficacyendpoint in preventing COVID-19 at interim analysis Subject: - ...
noTextDate: leeg!
ocrText: isoweek-2021 isoweek-2022 |Ct-waarde 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 66bafb3f511bddc460cb60bcfb10f0da0f7c540d2ec33c453b1220a6af7e8929
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip_6320
textDigestSHA256: 86356d6f9cc28e92b63cebfdde5ffb46b95cc5108f815b63471b60e1c4d88316
ocrTextDigestSHA256: 34ea7743594f08b217c2e155c1f4035ef17e172d69327d310aa73507055b967b
extractedId: VWS-WOO-08-1245929
Archiefrij 4 — 2025-03-18 09:30:26
fromFile: 2024.075-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1245929-FW_AstraZeneca_-_AZD1222_US_Phase_III_trial_met_primary_efficacyendpoint_in_preventing_COVID-19_at_interim_analysis.pdf
documentType: pdf
documentCompressedSize: 259457
documentSize: 565585
documentCompressRatio: 45.87409496362174
documentDateModified: 2024-10-25 13:30:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1245929
To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]
Cc: @minvws.nl]
From: 5.1.2e N12
Sent: Mon3/22/20218:08:43 AM
Subject: FW: AstraZeneca-AZD1222 USPhase llltrial met primary efficacyendpoint inpreventing COVID-19 atinterim analysis
Received:Mon 3/22/2021 8:08:56 AM
Beste 2e
Jullie stonden...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 355312
textDigestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1245929
Archiefrij 5 — 2025-02-27 09:25:06
fromFile: 2022.252-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2022.252-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1245929-FW_AstraZeneca_-_AZD1222_US_Phase_III_trial_met_primary_efficacyendpoint_in_preventing_COVID-19_at_interim_analysis.pdf
documentType: pdf
documentCompressedSize: 259457
documentSize: 565585
documentCompressRatio: 45.87409496362174
documentDateModified: 2024-10-25 13:30:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1245929
To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]
Cc: @minvws.nl]
From: 5.1.2e N12
Sent: Mon3/22/20218:08:43 AM
Subject: FW: AstraZeneca-AZD1222 USPhase llltrial met primary efficacyendpoint inpreventing COVID-19 atinterim analysis
Received:Mon 3/22/2021 8:08:56 AM
Beste 2e
Jullie stonden...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 25, "email": "@minvws.nl", "context": "1245929 To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]"}, {"position": 49, "email": "@minvws.nl", "context": "@minvws.nl]; BE. BEIEEE @minvws.nl] Cc: @minvws.nl] From:"}, {"position": 65, "email": "@minvws.nl", "context": "BEIEEE @minvws.nl] Cc: @minvws.nl] From: 5.1.2e N12"}]
documentMailAdresses: [{"position": 25, "email": "@minvws.nl", "context": "1245929 To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]"}, {"position": 49, "email": "@minvws.nl", "context": "@minvws.nl]; BE. BEIEEE @minvws.nl] Cc: @minvws.nl] From:"}, {"position": 65, "email": "@minvws.nl", "context": "BEIEEE @minvws.nl] Cc: @minvws.nl] From: 5.1.2e N12"}]
digestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 268482
textDigestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1245929
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
documentName: VWS-WOO-08-1245929-FW_AstraZeneca_-_AZD1222_US_Phase_III_trial_met_primary_efficacyendpoint_in_preventing_COVID-19_at_interim_analysis.pdf
documentType: pdf
documentCompressedSize: 259457
documentSize: 565585
documentCompressRatio: 45.87409496362174
documentDateModified: 2024-10-25 13:30:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1245929
To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]
Cc: @minvws.nl]
From: 5.1.2e N12
Sent: Mon3/22/20218:08:43 AM
Subject: FW: AstraZeneca-AZD1222 USPhase llltrial met primary efficacyendpoint inpreventing COVID-19 atinterim analysis
Received:Mon 3/22/2021 8:08:56 AM
Beste 2e
Jullie stonden...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 25, "email": "@minvws.nl", "context": "1245929 To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]"}, {"position": 49, "email": "@minvws.nl", "context": "@minvws.nl]; BE. BEIEEE @minvws.nl] Cc: @minvws.nl] From:"}, {"position": 65, "email": "@minvws.nl", "context": "BEIEEE @minvws.nl] Cc: @minvws.nl] From: 5.1.2e N12"}]
documentMailAdresses: [{"position": 25, "email": "@minvws.nl", "context": "1245929 To:51.2e 5.1.2e| @minvws.nl]; BE. BEIEEE @minvws.nl]"}, {"position": 49, "email": "@minvws.nl", "context": "@minvws.nl]; BE. BEIEEE @minvws.nl] Cc: @minvws.nl] From:"}, {"position": 65, "email": "@minvws.nl", "context": "BEIEEE @minvws.nl] Cc: @minvws.nl] From: 5.1.2e N12"}]
digestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 57618
textDigestSHA256: 36fcafc2ba3fac02075104d5559738be865ac677bed2dd095742bc34dc63257c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1245929
(dit is ook een speeltuin)